Report #2871597

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Oct 19, 2025
Onset: Oct 1, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (3)

InflammationLethargyPain in extremity

Symptom narrative

sore arm; lethargy; inflammation; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 19-OCT-2025, the patient received Shingrix. In OCT-2025, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: sore arm), lethargy (Verbatim: lethargy) and inflammation (Verbatim: inflammation). The outcome of the pain in arm, lethargy and inflammation were unknown. The reporter considered the pain in arm, lethargy and inflammation to be related to Shingrix. The company considered the pain in arm, lethargy and inflammation to be related to Shingrix. Additional Information: GSK receipt Date: 20-OCT-2025 Patient had sore arm, lethargy and inflammation.